Xcelience Launches Drug Development Consulting Service

January 18, 2007, Tampa, FL - Xcelience, LLC, a Tampa-based pharmaceutical development company, has launched a product-development consulting service to help its growing client base in planning, executing and evaluating the development of drug products. After working with a wide range of clients across North America, Xcelience has recognized the need from both small and virtual clients to further supplement their current service offerings by providing these drug development services. Consultant participation will be available at the task, project and program level.

This consulting service will use specialized expertise within Xcelience's scientific staff and will be spearheaded by Dr. Steve Bannister, Xcelience's Scientific Director and Principal Consultant. Dr. Bannister has 23 years of experience in the area of managing and consulting in the pharmaceutical industry. His scientific training and experience includes pharmaceutics, analytical chemistry, bioanalysis, and pharmacokinetics. He has managed components of product development at the laboratory level and directed integrated discovery and development functions at the executive level.

Xcelience is excited about offering valuable expertise to clients as a complement to its successful drug development based services. "The ultimate goal is to assist our clients in being successful. Whether the task is an accelerated plan of getting to First in Human Studies, achieving a "milestone payment" date or developing the right formulation at each step, Xcelience hopes that by offering this service, we will be assisting others to bring more meaningful compounds from ideas to reality," said its Vice President Randall Guthrie.

For more information, log on to www.xcelience.com and find the link for Xpert Consulting.

About the Business
Xcelience is the premier source for unsurpassed quality in drug discovery. The company brings together the industry's most experienced and talented scientists, consistently and efficiently moving compounds through the research and development stages to market.

Since 1997, the Tampa-based laboratory has been developing formulations for clients throughout the country. Xcelience's unique corporate structure creates project teams which work intensively with each client, becoming an extension of their own organization into the Xcelience lab.

The lab uses only state-of-the art equipment, highlighted by the patented Xcelodose™ which fills API directly to capsules — the only machine of its kind on the continent (Xcelodose™ is a registered trademark of Capsugel). This and other technologies give Xcelience unparalleled speed to market without compromising its absolute commitment to quality.

Located less than five-minutes from Tampa International Airport, the lab is close to accommodations, and convenient for clients with time-sensitive needs.
www.xcelience.com

Public Relations Contact:
Mike Nabors
Director of Communications
Teasdale Worldwide
(813) 868-1524

# # #